Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gris

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' studyG Lissalde-Lavigne, P Fabbro-Peray, E Cochery-Nouvellon, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 7, 2020
Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic stateA D Makatsariya, E V Slukhanchuk, V O Bitsadze, et al.
Journal of Thrombosis and Haemostasis : JTH|January 17, 2015
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trialG Lavigne-Lissalde, A G Aya, F J Mercier, et al.
Thrombosis and Haemostasis|August 26, 2000
Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHAJ C Gris, I Quéré, M Sanmarco, et al.
Journal De Medecine Vasculaire|February 15, 2020
Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)H Rafii, C Frère, I Benzidia, et al.
Annals of the Rheumatic Diseases|September 20, 2008
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patientsR Cervera, M A Khamashta, Y Shoenfeld, et al.
Annals of the Rheumatic Diseases|January 28, 2014
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsR Cervera, R Serrano, G J Pons-Estel, et al.
The Journal of Frailty & Aging|November 25, 2016
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, R Bourret, T Camuzat, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' studyG Lissalde-Lavigne, P Fabbro-Peray, E Cochery-Nouvellon, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 7, 2020
Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic stateA D Makatsariya, E V Slukhanchuk, V O Bitsadze, et al.
Journal of Thrombosis and Haemostasis : JTH|January 17, 2015
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trialG Lavigne-Lissalde, A G Aya, F J Mercier, et al.
Thrombosis and Haemostasis|August 26, 2000
Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHAJ C Gris, I Quéré, M Sanmarco, et al.
Journal De Medecine Vasculaire|February 15, 2020
Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)H Rafii, C Frère, I Benzidia, et al.
Annals of the Rheumatic Diseases|September 20, 2008
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patientsR Cervera, M A Khamashta, Y Shoenfeld, et al.
Annals of the Rheumatic Diseases|January 28, 2014
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsR Cervera, R Serrano, G J Pons-Estel, et al.
The Journal of Frailty & Aging|November 25, 2016
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, R Bourret, T Camuzat, et al.
Pageof 12